SC 13D 1 dsc13d.htm SCHEDULE 13D Schedule 13D

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13D-1(A) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13D-2(A)

 

 

Shamir Optical Industry Ltd.

(Name of Issuer)

 

 

Ordinary Shares, par value 0.01 NIS per share

(Title and Class of Securities)

M83683108

(CUSIP Number)

Essilor International

147, rue de Paris

94227 Charenton-le-Pont

France

Attention: Director for Legal Affairs

and Group Development

 

 

Copy to:

Linda Hesse

Jones Day

2, rue Saint-Florentin

75001 Paris

France

+33.1.56.59.39.39

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

October 15, 2010

(Date of Event which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box  ¨.

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


 

    CUSIP No. M83683108

   13D    2
  1   

NAMES OF REPORTING PERSONS

 

Essilor International

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS

 

    WC

  5  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

    ¨

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    France

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

  

  7 

  

SOLE VOTING POWER

 

    0

  

  8

  

SHARED VOTING POWER

 

    11,620,399 (see Introduction and Item 5)

  

  9

  

SOLE DISPOSITIVE POWER

 

    0

  

10

  

SHARED DISPOSITIVE POWER

 

    0

11

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    11,620,399 (see Introduction and Item 5)

12

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

    ¨

13

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

    69.3%*

14

 

TYPE OF REPORTING PERSON

 

    CO

 

*

Based on 16,778,908 ordinary shares of the issuer reported outstanding on the issuer’s Annual Report on Form 20-F for the fiscal year ending December 31, 2009.


 

    CUSIP No. M83683108

   13D    3

 

  1   

NAMES OF REPORTING PERSONS

 

Shamrock Acquisition Sub Ltd.

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  x

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS

 

    WC

  5  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

    ¨

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Israel

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

  

  7 

  

SOLE VOTING POWER

 

    0

  

  8

  

SHARED VOTING POWER

 

    11,620,399 (see Introduction and Item 5)

  

  9

  

SOLE DISPOSITIVE POWER

 

    0

  

10

  

SHARED DISPOSITIVE POWER

 

    0

11

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    11,620,399 (see Introduction and Item 5)

12

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

    ¨

13

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

    69.3%*

14

 

TYPE OF REPORTING PERSON

 

    CO

*

Based on 16,778,908 ordinary shares of the issuer reported outstanding on the issuer’s Annual Report on Form 20-F for the fiscal year ending December 31, 2009.


 

    CUSIP No. M83683108

   13D    4

 

Introduction.

This statement on Schedule 13D (this “Schedule 13D”) relates to the Agreement and Plan of Merger, dated as of October 15, 2010 (the “Merger Agreement”), by and among Essilor International, a French société anonyme (the “Parent”), Shamrock Acquisition Sub Ltd., an Israeli company and a direct wholly-owned subsidiary of the Parent (“Merger Sub”), and Shamir Optical Industry Ltd., an Israeli company (the “Company”), and the transactions contemplated thereby. The Merger Agreement contemplates that, subject to the terms and conditions set forth therein, Merger Sub will be merged with and into the Company, with the Company continuing after the merger as the surviving corporation (the “Merger”). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of the Company’s ordinary shares, par value 0.01 NIS per share (the “Company Shares”), not held, directly or indirectly, by Kibbutz Shamir A.C.S., an Israeli agricultural cooperative society (the “Kibbutz”) or Shamir Optica Holdings, A.C.S., an Israeli agricultural cooperative society currently wholly-owned by the Kibbutz that will be converted into an Israeli company prior to the consummation of the Merger (“Shamir Holding”), will be converted into the right to receive $14.50 in cash, without interest and less any applicable withholding taxes, and such Company Shares will be owned by Parent.

In connection with the execution of the Merger Agreement, the Parent and Merger Sub have entered into Support Agreements (the “Support Agreements”) with (i) the Kibbutz and Shamir Holding, dated as of October 15, 2010, (ii) Mr. Dan Katzman, dated as of October 15, 2010, (iii) Haklaei Eyal Ha’Sharon Ltd., dated as of October 15, 2010, and (iv) Eyal Microwave Ltd., dated as of October 15, 2010, each as a shareholder of the Company (collectively, the “Shareholders”) pursuant to which the Shareholders have agreed, among other things, and in accordance with and subject to the terms and conditions set forth therein (i) to vote their Company Shares in favor of the Merger Agreement and the transactions contemplated thereby, including the Merger and (ii) to certain restrictions on the transfer of their Company Shares.

Pursuant to the Share Purchase and Subscription Agreement, dated as of October 15, 2010 by and among the Kibbutz, Shamir Holding and the Parent (the “Share Purchase and Subscription Agreement”), (i) simultaneously with and subject to the occurrence of the Merger, the Parent will purchase from the Kibbutz 550,000 Company Shares (the “Kibbutz Share Sale”) and, (ii) immediately following the Merger, the Parent will, (x) subscribe for certain newly issued shares in Shamir Holding, in exchange for cash consideration (the “First Shamir Holding Subscription”) and (y) subscribe for additional Shamir Holding shares in exchange for the contribution by the Parent of all of the Company Shares then held directly by the Parent to Shamir Holding (the “Second Shamir Holding Subscription”), such that, immediately following the Kibbutz Share Sale, the First Shamir Holding Share Subscription, and the Second Shamir Holding Share Subscription, Shamir Holding will own, directly, 100% of all outstanding Company Shares and the Parent will beneficially own 50% of all outstanding Company Shares.

The descriptions of the Merger Agreement, Support Agreements and Share Purchase and Subscription Agreement (the “Transaction Agreements”) are qualified in their entirety by the terms and conditions of the Merger Agreement, Support Agreements and Share Purchase and Subscription Agreement, which are filed as Exhibits 99.2 through 99.7 hereto, and are incorporated herein by reference.

 

Item 1. Security and Issuer.

The class of equity security to which this Schedule 13D relates is the Company Shares of the Company. The Company’s principal executive offices are located at the Kibbutz, Upper Galilee, 12135, Israel.

 

Item 2. Identity and Background.

This Schedule 13D is being filed by the Parent and Merger Sub (the “Reporting Persons”). The Reporting Persons have entered into a Joint Filing Agreement, dated as of the date hereof, a copy of which is filed with this Schedule 13D as Exhibit 99.1 (which is hereby incorporated by reference) pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the “Act”). The Reporting Persons are filing this Schedule 13D because they may be deemed to be a “group” within the meaning of Section 13(d)(3) of the Act with respect to the transaction described in Item 4 of this Schedule 13D. The Reporting Persons expressly disclaim that they have agreed to act as a group except as described herein.


 

    CUSIP No. M83683108

   13D    5

 

(a) – (c) The Parent is a French société anonyme with its principal executive offices located at 147 rue de Paris, 94220 Charenton-le-Pont, France. The Parent is a maker of ophthalmic products and supplies.

Merger Sub is a company organized under the laws of Israel and is a direct wholly-owned subsidiary of the Parent, with its principal executive offices located at 31 Hillel St., Jerusalem, Israel 91000. Merger Sub was formed for the specific purpose of consummating the Merger and the other transactions contemplated by the Merger Agreement, and will cease to exist upon consummation of the Merger.

Set forth in Schedule I to this Schedule 13D and incorporated herein by reference is the following information with respect to each director and executive officer of the Reporting Persons: (1) name; (2) business address; (3) principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted; and (4) citizenship.

(d) – (e) None of the Reporting Persons or, to the knowledge of the Reporting Persons, any person named on Schedule I, has during the last five years been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to any civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or a finding of any violation with respect to such federal or state securities laws.

 

Item 3. Source and Amount of Funds or Other Consideration.

The total value of the Merger transaction, including the amount of funds required by the Parent to pay the aggregate consideration pursuant to the Merger Agreement and the transactions contemplated thereby, and pay fees and expenses relating to the Merger, will be approximately $135,000,000. The Parent plans to obtain the funds from existing cash resources, including current availability under its existing credit facilities.

 

Item 4. Purpose of Transaction.

On October 15, 2010, the Company, the Parent and Merger Sub entered into the Merger Agreement. Pursuant to the Merger Agreement, and upon the terms and subject to the conditions thereof, Merger Sub will be merged with and into the Company, and each outstanding Company Share (other than shares held, directly or indirectly, by the Kibbutz and Shamir Holding, shares held by the Parent or Merger Sub or any of their subsidiaries and shares considered to be “dormant shares” (menayah redumah) under Israeli law) will be converted into the right to receive $14.50 in cash, without interest (the “Merger Consideration”).

In addition, (i) all outstanding vested options for Company Shares will be exercised (either voluntarily by the holder, or through amendment of the underlying company benefit plan) and the Merger Consideration, less the exercise price, will be paid to the holders thereof (or held by the trustee, if the receipt of consideration on a tax favorable basis remains subject to the expiration of a holding period under Israeli law), and the exercise price will be paid to the Company, and (ii) all outstanding unvested options will be cancelled upon consummation of the Merger, and the holders thereof will not be entitled to any consideration, unless the exercise price is lower than the Merger Consideration, in which case holders thereof will be entitled to receive the Merger Consideration less the exercise price of such options on the same basis as holders of vested options, but subject to the additional condition that the right of such holders to receive such consideration will be subject to the holder’s continued employment or service through the applicable vesting dates and according to the original vesting schedule. The consideration payable in connection with vested options will be paid by the paying agent, and funded by the Parent, and the consideration payable in connection with the unvested options will be shared equally by the Parent and the Kibbutz. As a result of the foregoing, the number of shares that have vested at the date of consummation of the Merger will affect the exact aggregate consideration paid pursuant to the Merger Agreement.

As part of the Merger Agreement, the Company undertook, subject to certain exceptions, not to distribute declare or distribute any dividends, other than (i) a cash dividend by the Company not in excess of $13,500,000 in the aggregate, (ii) the declaration and payment of cash dividends by Subsidiaries (as defined in the Merger Agreement) of the Company not in excess of $500,000 in the aggregate, and (iii) dividends paid as part of the Company’s cash management system by any wholly-owned Subsidiary of the Company to the Company or to any wholly-owed Subsidiary of the Company. In addition, as part of a shareholders agreement to be entered into upon closing, a dividend policy has been agreed for the period after the consummation of the Merger.


 

    CUSIP No. M83683108

   13D    6

 

Also as part of the Merger Agreement, the Company further undertook, subject to certain exceptions and conditions more fully described in the Merger Agreement, not to directly or indirectly (i) solicit, initiate or knowingly facilitate or knowingly encourage the submission of offers for a merger or business combination or similar transaction and other potentially competitive transactions (including certain share sales, asset sales, licensing arrangements and other transactions), as more specifically defined in the Merger Agreement (“Company Alternative Proposal”), (ii) participate in any negotiations regarding, or furnish to any Person any nonpublic information with respect to, or in furtherance of, any Company Alternative Proposal, (iii) engage in discussions with any Person with respect to any Company Alternative Proposal, (iv) withhold, withdraw or modify in a manner adverse to the Parent, the recommendation of the Company’s Board of Directors to its shareholders that they approve the Merger Agreement, the Merger, the shareholders agreement to be entered into upon consummation of the Merger, and the other transactions contemplated thereby, (v) agree to, accept, approve, endorse or recommend any Company Alternative Proposal, (vi) enter into any letter of intent or similar document or any agreement or commitment providing for any Company Alternative Proposal, (vii) enter into any agreement or any agreement in principle requiring the Company to materially delay, abandon, terminate or fail to consummate the Merger Agreement, the Merger, the shareholders agreement to be entered into upon consummation of the Merger, and the other transactions contemplated thereby.

In connection with the transactions, certain commercial and related agreements will be entered into at closing, and certain existing commercial and related agreements will be amended at closing. These agreements include but are not limited to services related to design, development and distribution of products, as well as R&D, licensing, leases, manpower services and supplies.

The Merger remains subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, including obtaining approval of the shareholders of the Company in accordance with Israeli law and the approval of the district court of Nazareth, Israel.

In connection with the execution of the Merger Agreement, the Parent and Merger Sub have entered into the Support Agreements with the Shareholders pursuant to which the Shareholders have agreed (i) to vote their Company Shares in favor of the Merger Agreement and the transactions contemplated thereby, including the Merger and (ii) to certain restrictions on the transfer of their Company Shares. The Support Agreements will terminate on the earliest to occur of various events including in particular if the Merger Agreement is terminated.

If the Merger is consummated, the Company Shares will no longer be traded on either The NASDAQ Global Market or the Tel Aviv Stock Exchange and will be deregistered under the Act.

At the same time as the Merger, the Parent will purchase from the Kibbutz 550,000 Company Shares and will subscribe, in two steps, for newly issued Shamir Holding shares such that each of the Parent and the Kibbutz will, at the conclusion of the transactions, beneficially own 50% of the Company Shares. Pursuant to the transactions contemplated by the Transaction Agreements, the Parent and the Kibbutz will each have the right to name four members of the board of directors of each of the Company and Shamir Holding after the consummation of the Merger.

Except as described above, none of the Reporting Persons or, to the knowledge of the Reporting Persons, any person named on Schedule I, has current plans or proposals that would result in the types of transactions set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.


 

    CUSIP No. M83683108

   13D    7

 

Item 5. Interest in Securities of the Issuer.

(a) – (b) As described in Item 4 of this Schedule 13D, the Shareholders and the Reporting Persons formed a group as a result of entering into the Support Agreements and the Reporting Persons may be deemed to have beneficial ownership of 11,620,399 outstanding Company Shares (representing approximately 69.3% of the outstanding Company Shares) owned by the Shareholders. All of the percentages calculated in this Schedule 13D are based upon an aggregate of 16,778,908 Company Shares reported outstanding on the issuer’s Annual Report on Form 20-F for the fiscal year ending December 31, 2009.

The Reporting Persons have joined in the filing of this Schedule 13D because Merger Sub is the Parent’s wholly-owned subsidiary.

The number of Company Shares that may be deemed to be beneficially owned by the Reporting Persons with respect to which there is (i) sole voting power is none, (ii) shared voting power is 11,620,399, (iii) sole dispositive power is none, and (iv) shared dispositive power is none.

The filing of this Schedule 13D by the Reporting Persons shall not be considered an admission that the Reporting Persons, for the purpose of Section 13(d) of the Act, are the beneficial owners of any of the shares of Company Shares covered in this report, and the Reporting Persons expressly disclaim such beneficial ownership.

To the knowledge of the Reporting Persons, none of the persons named on Schedule I beneficially owns or has power to dispose of any Company Shares.

(c) None of the Reporting Persons, or, to the knowledge of the Reporting Persons, any person named in Schedule I, has effected any transaction in the Company Shares during the past 60 days.

(d) Not applicable.

(e) Not applicable.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

The responses to Items 1, 4 and 5 of this Schedule 13D and the exhibits to this Schedule 13D are incorporated herein by reference.

 

Item 7. Material to be Filed As Exhibits.

 

99.1   

Joint Filing Agreement By and Among Reporting Persons.

99.2   

Agreement and Plan of Merger, dated as of October 15, 2010, by and among the Parent, Merger Sub and the Company.

99.3   

Support Agreement, dated as of October 15, 2010, by and among the Parent, Merger Sub and the Kibbutz and accepted and agreed by Shamir Holding.

99.4   

Support Agreement, dated as of October 15, 2010, by and among the Parent, Merger Sub, and Dan Katzman.

99.5   

Support Agreement, dated as of October 15, 2010, by and among the Parent, Merger Sub and Haklaei Eyal Ha’Sharon Ltd.

99.6   

Support Agreement, dated as of October 15, 2010, by and among the Parent, Merger Sub and Eyal Microwave Ltd.

99.7   

Share Purchase and Subscription Agreement, dated as of October 15, 2010, by and among Shamir Holding, Kibbutz and the Parent.


 

    CUSIP No. M83683108

   13D    8

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: October 25, 2010

 

ESSILOR INTERNATIONAL

By:

 

/s/    Carol Xueref        

Name:   Carol Xueref
Title:    

Director for Legal Affairs and

Group Development

SHAMROCK ACQUISITION SUB LTD.

By:

 

/s/    Carol Xueref        

Name:   Carol Xueref
Title:     Director


 

    CUSIP No. M83683108

   13D    9

 

SCHEDULE I

Directors and Executive Officers of the Reporting Persons

 

Name

  

Business Address

  

Principal occupation or
employment and address

  

Citizenship

Board of Directors of Essilor International

Xavier Fontanet

  

Essilor International

147, rue de Paris

94220 Charenton-le-Pont

France

   Chairman, Essilor International    France

Hubert Sagnières

  

Essilor International

147, rue de Paris

94220 Charenton-le-Pont

France

  

Chief Executive Officer,

Essilor International

   France

Philippe Alfroid

  

Essilor International

147, rue de Paris

94220 Charenton-le-Pont

France

  

Retired

34, rue du Bac

75007 Paris

France

   France

Alain Aspect

  

Institut d’Optique

Campus Polytechnique

RD 128

91127 Palaiseau Cedex

France

  

Director of Research at CNRS (Institut d’Optique in Orsay)

 

Professor at Ecole Polytechnique and Institut d’Optique

Campus Polytechnique

RD 128

91127 Palaiseau Cedex

   France

Benoît Bazin

  

Saint-Gobain

Les Miroirs

18, avenue d’Alsace

92096 Paris La Défense

Cedex

France

  

Vice President,

Director, Building Distribution Sector

   France

Yves Chevillote

  

Essilor International

147, rue de Paris

94220 Charenton-le-Pont France

  

Retired

72 Blvd Malesherbes

75008 Paris

France

   France

Antoine Bernard

de Saint-Affrique

   Unilever   

Executive Vice President

100 Victoria Embankment Blackfriars

EC4P 4BQ London

United Kingdom

   France

Mireille Faugère

  

AP-HP

3, avenue Victoria

75184 Paris Cedex 04

   Chief Executive Officer    France


 

    CUSIP No. M83683108

   13D    10

Name

  

Business Address

  

Principal occupation or
employment and address

  

Citizenship

Yves Gillet

   Valoptec   

Director

c/o ESSILOR ESPAÑA, S.A. C/Labastida s/n

28034 Madrid

Spain

   France

Yi He

  

Essilor Holding Company

Unit D2 20/F,

398 Huaihai Road (M)

Shanghai - P.R.C. 200020, CHINA

   Shanghaï Essilor Optical Co LTD “Lab and Logistics”    China

Bernard Hours

   Danone   

Co-Chief Operating Officer

17, Boulevard Haussmann

75009 Paris

France

 

Mailing address:

15, rue du Helder

75439 PARIS Cedex 09

France

   France

Maurice

Marchand-Tonel

  

European American

Chamber of Commerce

  

Chairman of the European American Chamber of Commerce (France)

 

Private address:

11, Avenue de Suffren

75007 Paris

France

   France

Aïcha Mokdahi

  

147, rue de Paris

94220 Charenton-le-Pont France

   President, Valoptec    France

Olivier Pécoux

  

Rothschild et Cie

23 bis avenue de Messine 75008 Paris

France

   Managing Partner    France

Michel Rose

  

Lafarge S.A.

61, rue des Belles Feuilles 75782 Paris Cedex 16

France

  

Retired

13, rue du Gravier

60930 Bailleul sur Therain France

   France

Alain Thomas

  

147, rue de Paris

94220 Charenton-le-Pont France

   Director, Valoptec    France


 

    CUSIP No. M83683108

   13D    11

Name

  

Business Address

  

Principal occupation or
employment and address

  

Citizenship

Officers of Essilor International

Thomas Bayer

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   President, Latin America    Germany

Jean Carrier-Guillomet

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   President, Essilor of America    France

Patrick Cherrier

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   President, Asia Region    France

Eric Leonard

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   President, Europe Region    France

Bertrand Roy

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   Senior Vice President, Strategic Partnerships    France

Laurent Vacherot

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   Chief Operating Officer and Chief Financial Officer    France

Carol Xueref

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   Corporate Senior Vice President, Legal Affairs and Development    Great Britain

Paul du Saillant

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   Chief Operating Officer    France
Director of Shamrock Acquisition Sub Ltd.

Carol Xueref

  

147, rue de Paris, 94220

Charenton-le-Pont, France

   Corporate Senior Vice President, Legal Affairs and Development, Essilor International    Great Britain